Peer-Reviewed Journal Details
Mandatory Fields
Chen, X.,Lee, G.,Maher, B. S.,Fanous, A. H.,Chen, J.,Zhao, Z.,Guo, A.,van den Oord, E.,Sullivan, P. F.,Shi, J.,Levinson, D. F.,Gejman, P. V.,Sanders, A.,Duan, J.,Owen, M. J.,Craddock, N. J.,O'Donovan, M. C.,Blackman, J.,Lewis, D.,Kirov, G. K.,Qin, W.,Schwab, S.,Wildenauer, D.,Chowdari, K.,Nimgaonkar, V.,Straub, R. E.,Weinberger, D. R.,O'Neill, F. A.,Walsh, D.,Bronstein, M.,Darvasi, A.,Lencz, T.,Malhotra, A. K.,Rujescu, D.,Giegling, I.,Werge, T.,Hansen, T.,Ingason, A.,Noethen, M. M.,Rietschel, M.,Cichon, S.,Djurovic, S.,Andreassen, O. A.,Cantor, R. M.,Ophoff, R.,Corvin, A.,Morris, D. W.,Gill, M.,Pato, C. N.,Pato, M. T.,Macedo, A.,Gurling, H. M.,McQuillin, A.,Pimm, J.,Hultman, C.,Lichtenstein, P.,Sklar, P.,Purcell, S. M.,Scolnick, E.,St Clair, D.,Blackwood, D. H.,Kendler, K. S.
2011
November
Molecular Psychiatry
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia
Published
()
Optional Fields
16
1111
1117
29
We conducted data-mining analyses using the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and molecular genetics of schizophrenia genome-wide association study supported by the genetic association information network (MGS-GAIN) schizophrenia data sets and performed bioinformatic prioritization for all the markers with P-values
1476-5578 (Electronic)13
http://www.ncbi.nlm.nih.gov/pubmed/20838396
Grant Details
Publication Themes